Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, D Bassett, P Boyce… - Australian & New …, 2015 - journals.sagepub.com
Objectives: To provide guidance for the management of mood disorders, based on scientific
evidence supplemented by expert clinical consensus and formulate recommendations to …

Pharmacological treatment for generalized anxiety disorder in adults: an update

JA Reinhold, K Rickels - Expert opinion on pharmacotherapy, 2015 - Taylor & Francis
Introduction: Modest response and remission rates for the selective serotonin reuptake
inhibitors and the serotonin-norepinephrine reuptake inhibitors, coupled with mounting …

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

CU Correll, J Detraux, J De Lepeleire… - World …, 2015 - Wiley Online Library
People with severe mental illness have a considerably shorter lifespan than the general
population. This excess mortality is mainly due to physical illness. Next to mental illness …

Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo …

EJ Lenze, BH Mulsant, DM Blumberger, JF Karp… - The Lancet, 2015 - thelancet.com
Background Treatment-resistant major depression is common and potentially life-
threatening in elderly people, in whom little is known about the benefits and risks of …

Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review

JR Richards, TE Albertson, RW Derlet… - Drug and alcohol …, 2015 - Elsevier
Background Overdose of amphetamine, related derivatives, and analogues (ARDA)
continues to be a serious worldwide health problem. Patients frequently present to the …

Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials

KG Jensen, K Juul, A Fink-Jensen, CU Correll… - Journal of the American …, 2015 - Elsevier
Objective To evaluate the effect of antipsychotics on the corrected QT (QTc) interval in youth.
Method We searched PubMed (http://www. ncbi. nlm. nih. gov/pubmed) for randomized or …

Interventions for neuropsychiatric symptoms in neurocognitive impairment due to Alzheimer's disease: a review of the literature

TD McClam, CM Marano, PB Rosenberg… - Harvard review of …, 2015 - journals.lww.com
Neurocognitive impairment due to Alzheimer's disease (previously termed Alzheimer's
dementia)(AD) is the most common form of cognitive impairment worldwide. Given the …

Citalopram, QTc prolongation, and torsades de pointes

RR Tampi, M Balderas, KV Carter, DJ Tampi, M Moca… - Psychosomatics, 2015 - Elsevier
Objectives The aim of this systematic review is to identify case reports of citalopram use
resulting in QTc prolongation, torsades de pointes, or both, in the medical literature. Methods …

[HTML][HTML] Antipsychotic medication and QT prolongation

PS Chohan, R Mittal, A Javed - Pakistan journal of medical …, 2015 - ncbi.nlm.nih.gov
The QT interval represents ventricular depolarisation and repolarisation. Prolongation of this
interval can lead to life-threatening complications. These can include arrhythmias such as …

Are ECG monitoring recommendations before prescription of QT‐prolonging drugs applied in daily practice? The example of haloperidol

MJ Warnier, FH Rutten, PC Souverein… - … and drug safety, 2015 - Wiley Online Library
Purpose Monitoring of the QT duration by electrocardiography (ECG) prior to treatment is
frequently recommended in the label of QT‐prolonging drugs. It is, however, unknown how …